246 related articles for article (PubMed ID: 11568011)
1. Hypodiploidy is a major prognostic factor in multiple myeloma.
Smadja NV; Bastard C; Brigaudeau C; Leroux D; Fruchart C;
Blood; 2001 Oct; 98(7):2229-38. PubMed ID: 11568011
[TBL] [Abstract][Full Text] [Related]
2. Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma.
Calasanz MJ; Cigudosa JC; Odero MD; García-Foncillas J; Marín J; Ardanaz MT; Rocha E; Gullón A
Br J Haematol; 1997 Aug; 98(2):418-25. PubMed ID: 9266942
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
[TBL] [Abstract][Full Text] [Related]
4. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
Oh S; Koo DH; Kwon MJ; Kim K; Suh C; Min CK; Yoon SS; Shin HJ; Jo DY; Kwak JY; Kim JS; Sohn SK; Joo YD; Eom HS; Kim SH; Kim YS; Kim C; Mun YC; Kim H; Lee DS; Lee JH;
Ann Hematol; 2014 Aug; 93(8):1353-61. PubMed ID: 24671365
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases.
Smadja NV; Fruchart C; Isnard F; Louvet C; Dutel JL; Cheron N; Grange MJ; Monconduit M; Bastard C
Leukemia; 1998 Jun; 12(6):960-9. PubMed ID: 9639426
[TBL] [Abstract][Full Text] [Related]
7. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
[TBL] [Abstract][Full Text] [Related]
8. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
9. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
[TBL] [Abstract][Full Text] [Related]
10. Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study.
Jackson JF; Boyett J; Pullen J; Brock B; Patterson R; Land V; Borowitz M; Head D; Crist W
Cancer; 1990 Sep; 66(6):1183-9. PubMed ID: 2205354
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.
Tricot G; Barlogie B; Jagannath S; Bracy D; Mattox S; Vesole DH; Naucke S; Sawyer JR
Blood; 1995 Dec; 86(11):4250-6. PubMed ID: 7492784
[TBL] [Abstract][Full Text] [Related]
12. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China.
Mei J; Zhai Y; Li H; Li F; Zhou X; Song P; Zhao Q; Yu Y; An Z; Wang L
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2263-2273. PubMed ID: 30167888
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
[TBL] [Abstract][Full Text] [Related]
15. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
[TBL] [Abstract][Full Text] [Related]
17. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic abnormalities on the prognoses and clinical parameters of patients with multiple myeloma.
Jekarl DW; Min CK; Kwon A; Kim H; Chae H; Kim M; Lim J; Kim Y; Han K
Ann Lab Med; 2013 Jul; 33(4):248-54. PubMed ID: 23826560
[TBL] [Abstract][Full Text] [Related]
19. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.
Clark RE; Geddes AD; Whittaker JA; Jacobs A
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1789-93. PubMed ID: 2632260
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cytogenetics in multiple myeloma.
Seong C; Delasalle K; Hayes K; Weber D; Dimopoulos M; Swantkowski J; Huh Y; Glassman A; Champlin R; Alexanian R
Br J Haematol; 1998 Apr; 101(1):189-94. PubMed ID: 9576200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]